| Affected Systems |
|
|
|
|
|
|
|
cardiovascular system
|
√
|
√
|
√
|
√
|
√
|
|
abnormal angiogenesis
|
|
√
|
|
|
|
|
patent ductus arteriosus
|
|
√
|
|
√
|
|
|
abnormal vascular smooth muscle morphology
|
|
√
|
|
|
|
|
abnormal myocardial fiber morphology
|
√
|
|
√
|
|
|
|
abnormal intercalated disk morphology
|
|
|
√
|
|
√
|
|
abnormal myocardial fiber myofibril morphology
|
|
|
√
|
|
√
|
|
myocardial fiber degeneration
|
|
|
√
|
|
√
|
|
myocardial fiber disarray
|
|
|
√
|
|
|
|
increased heart atrium size
|
|
|
|
|
√
|
|
enlarged heart
|
|
|
√
|
|
√
|
|
increased heart ventricle size
|
|
|
|
|
√
|
|
pericardial effusion
|
|
|
√
|
|
√
|
|
cardiac fibrosis
|
|
|
√
|
|
√
|
|
dilated cardiomyopathy
|
|
|
√
|
|
√
|
|
decreased cardiac muscle contractility
|
|
|
√
|
|
√
|
|
abnormal heart echocardiography feature
|
|
|
|
|
√
|
cellular
|
√
|
√
|
√
|
√
|
√
|
|
patent ductus arteriosus
|
|
√
|
|
√
|
|
|
abnormal myocardial fiber myofibril morphology
|
|
|
√
|
|
√
|
|
increased cardiomyocyte apoptosis
|
√
|
|
√
|
|
|
growth/size/body
|
|
|
√
|
|
√
|
|
enlarged heart
|
|
|
√
|
|
√
|
homeostasis/metabolism
|
|
√
|
√
|
|
√
|
|
pericardial effusion
|
|
|
√
|
|
√
|
|
abnormal cardiac thrombosis
|
|
|
|
|
√
|
|
abnormal atrial thrombosis
|
|
|
|
|
√
|
|
cyanosis
|
|
√
|
|
|
|
mortality/aging
|
|
√
|
√
|
√
|
√
|
|
premature death
|
|
|
√
|
|
√
|
|
postnatal lethality, complete penetrance
|
|
√
|
|
√
|
|
|
postnatal lethality, incomplete penetrance
|
|
|
|
|
√
|
muscle
|
√
|
√
|
√
|
|
√
|
|
abnormal vascular smooth muscle morphology
|
|
√
|
|
|
|
|
abnormal myocardial fiber morphology
|
√
|
|
√
|
|
|
|
abnormal intercalated disk morphology
|
|
|
√
|
|
√
|
|
abnormal myocardial fiber myofibril morphology
|
|
|
√
|
|
√
|
|
myocardial fiber degeneration
|
|
|
√
|
|
√
|
|
myocardial fiber disarray
|
|
|
√
|
|
|
|
dilated cardiomyopathy
|
|
|
√
|
|
√
|
|
decreased cardiac muscle contractility
|
|
|
√
|
|
√
|
|
increased cardiomyocyte apoptosis
|
√
|
|
√
|
|
|
|
abnormal sarcomere morphology
|
|
|
√
|
|
√
|